Volume | 67,224 |
|
|||||
News | - | ||||||
Day High | 13.59 | Low High |
|||||
Day Low | 12.72 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Entrada Therapeutics Inc | TRDA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
13.40 | 12.72 | 13.59 | 13.56 | 13.25 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
1,181 | 67,224 | US$ 13.26 | US$ 891,253 | - | 10.62 - 18.44 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:05:16 | formt | 100 | US$ 13.20 | USD |
Entrada Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
454.62M | 33.60M | - | 129.01M | -6.69M | -0.20 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Entrada Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRDA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 12.26 | 13.59 | 11.78 | 12.52 | 66,148 | 1.30 | 10.60% |
1 Month | 14.08 | 14.335 | 11.78 | 12.78 | 78,883 | -0.52 | -3.69% |
3 Months | 14.00 | 15.565 | 11.35 | 13.15 | 80,232 | -0.44 | -3.14% |
6 Months | 16.05 | 17.58 | 10.7501 | 13.97 | 83,022 | -2.49 | -15.51% |
1 Year | 12.51 | 18.44 | 10.62 | 14.38 | 80,385 | 1.05 | 8.39% |
3 Years | 26.50 | 36.85 | 5.12 | 15.14 | 87,497 | -12.94 | -48.83% |
5 Years | 26.50 | 36.85 | 5.12 | 15.14 | 87,497 | -12.94 | -48.83% |
Entrada Therapeutics Description
Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. |